首页 | 本学科首页   官方微博 | 高级检索  
     


Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage
Authors:Prymula Roman  Hanovcova Irena  Splino Miroslav  Kriz Pavla  Motlova Jitka  Lebedova Vera  Lommel Patricia  Kaliskova Eva  Pascal Thierry  Borys Dorota  Schuerman Lode
Affiliation:a Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic
b Centre of Laboratory Activities in Protection and Support of Public Health, National Institute of Public Health, Prague, Czech Republic
c GlaxoSmithKline, Prague, Czech Republic
d GlaxoSmithKline Biologicals, Wavre, Belgium
Abstract:
Keywords:11Pn-PD, 11-valent PCV with all serotypes conjugated to Protein D   AOM, acute otitis media   CI, confidence intervals   DTPa-HBV-IPV/Hib, combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b vaccine   IPD, invasive pneumococcal disease   MEF, middle ear fluid   MenACWY-TT, investigational tetravalent Neisseria meningitidis serogroups A, C, W-135 and Y tetanus toxoid-conjugate vaccine   NPP, group that did not receive prophylactic paracetamol   NTHi, non-typeable H. influenzae   OD, optical density   OMP, outer membrane protein   PCV, pneumococcal conjugate vaccines   PHiD-CV, 10-valent pneumococcal NTHi Protein D conjugate vaccine   POET, pneumococcal otitis efficacy trial   PP, group that received prophylactic paracetamol   SD, standard deviation   VE, vaccine efficacy
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号